{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:42:31Z","timestamp":1768264951772,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jaad.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of the American Academy of Dermatology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.jaad.2022.04.025","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T12:19:25Z","timestamp":1650629965000},"page":"754-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Sentinel lymph node biopsy in patients with clinical stage IIB\/C cutaneous melanoma: A national cohort study"],"prefix":"10.1016","volume":"87","author":[{"suffix":"III","given":"Richard J.","family":"Straker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cimarron E.","family":"Sharon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emily Y.","family":"Chu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John T.","family":"Miura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E.","family":"Ming","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giorgos C.","family":"Karakousis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"10304","key":"10.1016\/j.jaad.2022.04.025_bib1","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S0140-6736(21)01206-X","article-title":"Immune checkpoint inhibitors in melanoma","volume":"398","author":"Carlino","year":"2021","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.025_bib2","first-page":"CD011123","article-title":"Systemic treatments for metastatic cutaneous melanoma","volume":"2","author":"Pasquali","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.025_bib3","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/S1470-2045(21)00065-6","article-title":"Adjuvant pembrolizumab versus placebo in resected stage III melanoma (EORTC 1325-MG\/KEYNOTE-054): distant metastasis-free survival results from a double-blind, randomised, controlled, phase 3 trial","volume":"22","author":"Eggermont","year":"2021","journal-title":"Lancet Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.025_bib4","doi-asserted-by":"crossref","first-page":"S1314","DOI":"10.1016\/j.annonc.2021.08.2116","article-title":"LBA3 Pembrolizumab versus placebo after complete resection of high-risk stage II melanoma: efficacy and safety results from the KEYNOTE-716 double-blind phase III trial","volume":"32","author":"Luke","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/j.jaad.2022.04.025_bib6","author":"Goodman"},{"issue":"8","key":"10.1016\/j.jaad.2022.04.025_bib8","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1245\/s10434-018-6513-7","article-title":"Melanoma staging: American Joint Committee on cancer (AJCC) 8th edition and beyond","volume":"25","author":"Gershenwald","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.jaad.2022.04.025_bib9","author":"Network"},{"key":"10.1016\/j.jaad.2022.04.025_bib12","series-title":"AJCC Cancer Staging Manual","author":"Amin","year":"2017"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.025_bib15","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1093\/oxfordjournals.aje.a113284","article-title":"A review of goodness of fit statistics for use in the development of logistic regression models","volume":"115","author":"Lemeshow","year":"1982","journal-title":"Am J Epidemiol"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.025_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.025_bib17","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/pan\/mpl013","article-title":"Matching as nonparametric preprocessing for reducing model dependence in parametric causal inference","volume":"15","author":"Ho","year":"2007","journal-title":"Political Analysis"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.025_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.jaad.2022.04.025_bib19","year":"2021"},{"issue":"6","key":"10.1016\/j.jaad.2022.04.025_bib20","first-page":"472","article-title":"Melanoma staging: evidence-based changes in the American Joint Committee on Cancer eighth edition cancer staging manual","volume":"67","author":"Gershenwald","year":"2017","journal-title":"CA Cancer J Clin"},{"issue":"7","key":"10.1016\/j.jaad.2022.04.025_bib21","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa1310460","article-title":"Final trial report of sentinel-node biopsy versus nodal observation in melanoma","volume":"370","author":"Morton","year":"2014","journal-title":"N Engl J Med"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.025_bib22","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/0194599819899934","article-title":"Sentinel lymph node biopsy in head and neck melanoma: long-term outcomes, prognostic value, accuracy, and safety","volume":"162","author":"Hanks","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"issue":"7","key":"10.1016\/j.jaad.2022.04.025_bib23","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1001\/archsurg.2010.115","article-title":"Prognostic information from sentinel lymph node biopsy in patients with thick melanoma","volume":"145","author":"Scoggins","year":"2010","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.jaad.2022.04.025_bib24","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1245\/s10434-014-4211-7","article-title":"Sentinel lymph node biopsy in thick-melanoma patients (N=350): what is its prognostic role?","volume":"22","author":"Ribero","year":"2015","journal-title":"Ann Surg Oncol"},{"issue":"8","key":"10.1016\/j.jaad.2022.04.025_bib25","doi-asserted-by":"crossref","first-page":"2780","DOI":"10.1245\/s10434-012-2826-0","article-title":"Sentinel node biopsy in thin and thick melanoma","volume":"20","author":"Mozzillo","year":"2013","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.025_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2017.75.7724","article-title":"Sentinel lymph node biopsy and management of regional lymph nodes in melanoma: American Society of Clinical Oncology and Society of Surgical Oncology Clinical Practice Guideline update","volume":"36","author":"Wong","year":"2018","journal-title":"J Clin Oncol"},{"issue":"23","key":"10.1016\/j.jaad.2022.04.025_bib27","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1613210","article-title":"Completion dissection or observation for sentinel-node metastasis in melanoma","volume":"376","author":"Faries","year":"2017","journal-title":"N Engl J Med"},{"issue":"7","key":"10.1016\/j.jaad.2022.04.025_bib28","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1097\/DAD.0000000000001857","article-title":"Letter regarding editorial by Samuel Zagarella","volume":"43","author":"Faries","year":"2021","journal-title":"Am J Dermatopathol"},{"issue":"2","key":"10.1016\/j.jaad.2022.04.025_bib29","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ejso.2016.06.407","article-title":"Complications of sentinel lymph node biopsy for melanoma - a systematic review of the literature","volume":"43","author":"Moody","year":"2017","journal-title":"Eur J Surg Oncol"},{"issue":"1","key":"10.1016\/j.jaad.2022.04.025_bib30","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1001\/archsurg.140.1.85","article-title":"Identifying risk factors for complications following sentinel lymph node biopsy for melanoma","volume":"140","author":"Roaten","year":"2005","journal-title":"Arch Surg"},{"issue":"6","key":"10.1016\/j.jaad.2022.04.025_bib31","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1245\/ASO.2003.10.001","article-title":"Complications associated with sentinel lymph node biopsy for melanoma","volume":"10","author":"Wrightson","year":"2003","journal-title":"Ann Surg Oncol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.025_bib32","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1097\/01.sla.0000143271.32568.2b","article-title":"Lymphedema after complete axillary node dissection for melanoma: assessment using a new, objective definition","volume":"240","author":"Starritt","year":"2004","journal-title":"Ann Surg"},{"issue":"4","key":"10.1016\/j.jaad.2022.04.025_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/archderm.136.4.511","article-title":"Lymphedema after sentinel lymph node biopsy for cutaneous melanoma: a report of 5 cases","volume":"136","author":"Wrone","year":"2000","journal-title":"Arch Dermatol"},{"issue":"5","key":"10.1016\/j.jaad.2022.04.025_bib34","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1001\/jamaoncol.2021.0051","article-title":"Chronic immune-related adverse events following adjuvant anti-pd-1 therapy for high-risk resected melanoma","volume":"7","author":"Patrinely","year":"2021","journal-title":"JAMA Oncol"},{"issue":"3","key":"10.1016\/j.jaad.2022.04.025_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.1611","article-title":"Immune checkpoint inhibitors and immune-related adverse events in patients with advanced melanoma: a systematic review and network meta-analysis","volume":"3","author":"Chang","year":"2020","journal-title":"JAMA Netw Open"}],"container-title":["Journal of the American Academy of Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222006818?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0190962222006818?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,30]],"date-time":"2025-09-30T23:03:06Z","timestamp":1759273386000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0190962222006818"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0190962222006818"],"URL":"https:\/\/doi.org\/10.1016\/j.jaad.2022.04.025","relation":{},"ISSN":["0190-9622"],"issn-type":[{"value":"0190-9622","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sentinel lymph node biopsy in patients with clinical stage IIB\/C cutaneous melanoma: A national cohort study","name":"articletitle","label":"Article Title"},{"value":"Journal of the American Academy of Dermatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaad.2022.04.025","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 by the American Academy of Dermatology, Inc.","name":"copyright","label":"Copyright"}]}}